These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32305737)

  • 1. HPLC with electrochemical detection for determining homogentisic acid and its application to urine from rats fed tyrosine-enriched food.
    Kishi T; Kotani A; Umemura T; Hakamata H
    J Pharm Biomed Anal; 2020 Jul; 186():113253. PubMed ID: 32305737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine homogentisic acid and tyrosine: simultaneous analysis by liquid chromatography tandem mass spectrometry.
    Hughes AT; Milan AM; Christensen P; Ross G; Davison AS; Gallagher JA; Dutton JJ; Ranganath LR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 963():106-12. PubMed ID: 24952314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of homogentisic acid in urine for diagnosis of alcaptonuria: Capillary electrophoretic method optimization using experimental design.
    Öztekin N; Balta GS; Cansever MŞ
    Biomed Chromatogr; 2018 Jul; 32(7):e4216. PubMed ID: 29461623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of homogentisic acid by electrospray ionization mass spectrometry.
    Tokuhara Y; Ohara K; Morinishi T; Yamaguchi K; Tada S
    J Clin Lab Anal; 2023 Nov; 37(21-22):e24976. PubMed ID: 37877521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferences of homogentisic acid (HGA) on routine clinical chemistry assays in serum and urine and the implications for biochemical monitoring of patients with alkaptonuria.
    Curtis SL; Roberts NB; Ranganath LR
    Clin Biochem; 2014 May; 47(7-8):640-7. PubMed ID: 24373924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary homogentisic acid in alkaptonuric and healthy children.
    Oláh AV; Llyés I; Szoke A; Csízy I; Tóth J; Varga J
    Clin Chem Lab Med; 2003 Mar; 41(3):356-9. PubMed ID: 12705346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of novel visible-light region absorbance peaks in the urine after alkalization in patients with alkaptonuria.
    Tokuhara Y; Shukuya K; Tanaka M; Mouri M; Ohkawa R; Fujishiro M; Takahashi T; Okubo S; Yokota H; Kurano M; Ikeda H; Yamaguchi S; Inagaki S; Ishige-Wada M; Usui H; Yatomi Y; Shimosawa T
    PLoS One; 2014; 9(1):e86606. PubMed ID: 24466168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuria.
    Norman BP; Sutherland H; Wilson PJM; Rutland DA; Milan AM; Hughes AT; Davison AS; Khedr M; Jarvis JC; Gallagher JA; Bou-Gharios G; Ranganath LR
    J Inherit Metab Dis; 2024 Jul; 47(4):664-673. PubMed ID: 38487984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homogentisic acid interference in routine urine creatinine determination.
    Loken PR; Magera MJ; Introne W; Tortorelli S; Gavrilov D; Oglesbee D; Rinaldo P; Matern D; Raymond K
    Mol Genet Metab; 2010 May; 100(1):103-4. PubMed ID: 20138792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkaptonuria and ochronosis in three siblings. Ascorbic acid treatment monitored by urinary HGA excretion.
    Forslind K; Wollheim FA; Akesson B; Rydholm U
    Clin Exp Rheumatol; 1988; 6(3):289-92. PubMed ID: 3180550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of alcaptonuria: rapid analysis of homogentisic acid by HPLC.
    Bory C; Boulieu R; Chantin C; Mathieu M
    Clin Chim Acta; 1990 Jul; 189(1):7-11. PubMed ID: 2383921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria.
    Bernini A; Petricci E; Atrei A; Baratto MC; Manetti F; Santucci A
    Sci Rep; 2021 Nov; 11(1):22562. PubMed ID: 34799606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria.
    Milan AM; Hughes AT; Davison AS; Khedr M; Rovensky J; Psarelli EE; Cox TF; Rhodes NP; Gallagher JA; Ranganath LR
    Sci Rep; 2019 Jul; 9(1):10024. PubMed ID: 31296884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of plasma and urine 3-hydroxyglutaric acid, after separation from 2-hydroxyglutaric acid and other compounds of similar ion transition, by liquid chromatography-tandem mass spectrometry for the confirmation of glutaric aciduria type 1.
    Simon GA; Wierenga A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1097-1098():101-110. PubMed ID: 30218917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria.
    Ranganath LR; Milan AM; Hughes AT; Khedr M; Davison AS; Shweihdi E; Norman BP; Hughes JH; Bygott H; Luangrath E; Fitzgerald R; Psarelli EE; van Kan C; Laan D; Olsson B; Rudebeck M; Mankowitz L; Sireau N; Arnoux JB; Le Quan Sang KH; Jarvis JC; Genovese F; Braconi D; Santucci A; Zatkova A; Glasova H; Stančík R; Imrich R; Rhodes NP; Gallagher JA
    J Inherit Metab Dis; 2020 Jul; 43(4):737-747. PubMed ID: 31609457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homogentisic Acid-Based Whole-Cell Biosensor for Detection of Alkaptonuria Disease.
    Dhyani R; Shankar K; Bhatt A; Jain S; Hussain A; Navani NK
    Anal Chem; 2021 Mar; 93(10):4521-4527. PubMed ID: 33655752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous detection of diagnostic biomarkers of alkaptonuria, ornithine carbamoyltransferase deficiency, and neuroblastoma disease by high-performance liquid chromatography/tandem mass spectrometry.
    Hsu WY; Chen CM; Tsai FJ; Lai CC
    Clin Chim Acta; 2013 May; 420():140-5. PubMed ID: 23085206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum markers in alkaptonuria: simultaneous analysis of homogentisic acid, tyrosine and nitisinone by liquid chromatography tandem mass spectrometry.
    Hughes AT; Milan AM; Davison AS; Christensen P; Ross G; Gallagher JA; Dutton JJ; Ranganath LR
    Ann Clin Biochem; 2015 Sep; 52(Pt 5):597-605. PubMed ID: 25628464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment.
    Ranganath LR; Milan AM; Hughes AT; Dutton JJ; Fitzgerald R; Briggs MC; Bygott H; Psarelli EE; Cox TF; Gallagher JA; Jarvis JC; van Kan C; Hall AK; Laan D; Olsson B; Szamosi J; Rudebeck M; Kullenberg T; Cronlund A; Svensson L; Junestrand C; Ayoob H; Timmis OG; Sireau N; Le Quan Sang KH; Genovese F; Braconi D; Santucci A; Nemethova M; Zatkova A; McCaffrey J; Christensen P; Ross G; Imrich R; Rovensky J
    Ann Rheum Dis; 2016 Feb; 75(2):362-7. PubMed ID: 25475116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of nitisinone on homogentisic acid and tyrosine: a two-year survey of patients attending the National Alkaptonuria Centre, Liverpool.
    Milan AM; Hughes AT; Davison AS; Devine J; Usher J; Curtis S; Khedr M; Gallagher JA; Ranganath LR
    Ann Clin Biochem; 2017 May; 54(3):323-330. PubMed ID: 28081634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.